CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 243 enrolled
Drug / intervention
Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00687908
NCT00687908Phase 3Completed
CompareCT.gov

Efficacy and Safety Comparison of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel Versus Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel Vehicle Gel as a 6-month Acne Maintenance Treatment

Galderma R&D·interventional·Posted Jun 2, 2008·Updated Feb 18, 2021

In Brief

A Phase 3 clinical trial evaluating Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel and Vehicle Gel for Acne. Completed, enrolled 243 participants across 33 sites in 3 countries.

Detailed Summary

The purpose of this study is to demonstrate the efficacy of Adapalene 0.1% /Benzoyl Peroxide 2.5% Gel compared to its Vehicle Gel as an acne maintenance treatment in Subjects previously treated with Adapalene-BPO Gel or Adapalene-BPO Vehicle Gel both associated with Doxycycline Hyclate 100 mg. The safety of the two investigational treatments will also be assessed.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne
CountriesCanada, Puerto Rico, United States
Collaborators--

Timeline

Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 2, 2008
Enrollment StartNov 1, 2008
Primary CompletionJul 1, 2009
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 18.1 years ago

Interventions

Adapalene 0.1% / Benzoyl Peroxide 2.5% Geldrug

Topical Gel to the face, once daily in the evening for 24 weeks.

Vehicle Geldrug

Topical Gel to the face, once daily in the evening for 24 weeks.